By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher today said fourth quarter revenues for its Life Sciences & Diagnostics division rose to $681.9 million from $432.1 million a year ago.

The Washington-based conglomerate began reporting Life Sciences & Diagnostics as a separate segment this quarter. Reporting those businesses in the year-ago period also as its own segment, revenues for the three months ended Dec. 31, 2010 represented a 58 percent spike year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.